Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low‐Grade Gliomas Using Multiparametric MR Radiomic Features

Noninvasive detection of isocitrate dehydrogenase 1 mutation (IDH1(+)) and loss of nuclear alpha thalassemia/mental retardation syndrome X‐linked expression ((ATRX(–)) are clinically meaningful for molecular stratification of low‐grade gliomas (LGGs).

[1]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[2]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[3]  Nello Cristianini,et al.  An Introduction to Support Vector Machines and Other Kernel-based Learning Methods , 2000 .

[4]  Nello Cristianini,et al.  An Introduction to Support Vector Machines and Other Kernel-based Learning Methods , 2000 .

[5]  Alain Rakotomamonjy,et al.  Variable Selection Using SVM-based Criteria , 2003, J. Mach. Learn. Res..

[6]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[7]  O. Chinot,et al.  Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis , 2010, Acta Neuropathologica.

[8]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[9]  J. Peltier,et al.  Perfusion MRI as a Neurosurgical Tool for Improved Targeting in Stereotactic Tumor Biopsies , 2012, Stereotactic and Functional Neurosurgery.

[10]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[11]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[12]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[13]  D. Bihan.  Apparent Diffusion Coefficient and Beyond: What Diffusion MR Imaging Can Tell Us about Tissue Structure , 2013 .

[14]  D. Le Bihan.  Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. , 2013, Radiology.

[15]  Zhengrong Liang,et al.  Volumetric texture features from higher-order images for diagnosis of colon lesions via CT colonography , 2014, International Journal of Computer Assisted Radiology and Surgery.

[16]  S. Choi,et al.  Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging , 2014, Journal of Neuro-Oncology.

[17]  S. Li,et al.  Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel‐based radiographic study of 146 low‐grade gliomas , 2015, European journal of neurology.

[18]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[19]  D. Geng,et al.  Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours , 2016, European Radiology.

[20]  Joseph O. Deasy,et al.  Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images , 2015, Proceedings of the National Academy of Sciences.

[21]  S. Heiland,et al.  IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma , 2015, Scientific Reports.

[22]  Steven J. M. Jones,et al.  Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.

[23]  A. Olar,et al.  Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. , 2015, Seminars in radiation oncology.

[24]  H. Aburatani,et al.  Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas , 2016, Histopathology.

[25]  Yuanyuan Wang,et al.  Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma , 2017, European Radiology.

[26]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[27]  B. Yin,et al.  Detecting isocitrate dehydrogenase gene mutations in oligodendroglial tumors using diffusion tensor imaging metrics and their correlations with proliferation and microvascular density , 2016, Journal of Magnetic Resonance Imaging.

[28]  Yanqi Huang,et al.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[30]  Karra A. Jones,et al.  Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status , 2017, Journal of Neuro-Oncology.

[31]  T. Maehara,et al.  ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations , 2017, Brain Tumor Pathology.

[32]  Yuanyuan Wang,et al.  Anatomical location differences between mutated and wild-type isocitrate dehydrogenase 1 in low-grade gliomas , 2017, The International journal of neuroscience.

[33]  G. Reifenberger,et al.  European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.

[34]  Jennie W. Taylor,et al.  Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT , 2017, Acta Neuropathologica.

[35]  P. V. van Zijl,et al.  Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI , 2017, Magnetic resonance in medicine.

[36]  Wei Cao,et al.  Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma , 2017, Scientific Reports.

[37]  S. Kothari,et al.  Role of exponential apparent diffusion coefficient in characterizing breast lesions by 3.0 Tesla diffusion-weighted magnetic resonance imaging , 2017, Indian Journal of Radiology and Imaging.

[38]  Raymond Y Huang,et al.  Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas , 2017, Neuro-oncology.

[39]  Baojuan Li,et al.  Radiomics Strategy for Molecular Subtype Stratification of Lower‐Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI , 2018, Journal of magnetic resonance imaging : JMRI.

[40]  Jong-Hee Chang,et al.  Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas , 2018, American Journal of Neuroradiology.